{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:52:04Z","timestamp":1792003924754,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,19]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients with chronic kidney disease (CKD) experience atrial fibrillation more frequently. The balance of medical management for stroke prevention and bleeding events presents a challenging issue in CKD population. Left atrial appendage occlusion (LAAO) may be an effective solution for stroke prevention in patients who experience frequent bleeding with oral anticoagulants. However, the specific impact of CKD on the procedural success, complications, and outcomes of LAAO implantations remains underexplored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a search of various databases for articles published before October 31, 2023. This search yielded 7 studies, comparing outcomes between CKD and non-CKD cohorts undergoing LAAO implantation. Our analysis focused on CHA2DS2-VASc scores, average eGFR, use of oral anticoagulants, procedural success rates, procedural complications, and associated outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The meta-analysis included data from 2576 patients, with 1131 identified as having CKD. The CKD group also had higher CHA2DS2-VASc scores (4.7\u2005\u00b1\u20051.4 vs 4.0\u2005\u00b1\u20051.5; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) and HAS-BLED scores (3.8\u2005\u00b1\u20051.1 vs 3.1\u2005\u00b1\u20051.0; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) than the non-CKD group. CKD patients showed a nonreduction in procedural success rates and a nonsignificant increase in total complications. The risks of stroke and transient ischemic attack, major bleeding, and cardiovascular mortality were not significantly different between the 2 groups. However, a significantly lower rate of total mortality was observed in the non-CKD group (odds ratio: 0.43; 95% confidence interval, 0.32\u20130.60).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>While CKD is associated with a nonsignificant decrease in procedural success and a nonsignificant increase in complication risks, the outcomes of LAAO implantation are comparably favorable between CKD and non-CKD groups. Despite similar procedural outcomes, the CKD group exhibited a higher rate of all-cause mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000038935","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:11:15Z","timestamp":1721434275000},"page":"e38935","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Impact of chronic kidney disease on left atrial appendage occlusion: A meta-analysis of procedural outcomes and complications"],"prefix":"10.1097","volume":"103","author":[{"given":"Wei-Chieh","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhih-Yuan","family":"Shih","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Jui","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Fang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Chung","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Nan","family":"Fang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Yu","family":"Fang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan."},{"name":"Division of Cardiology, Department of Internal Medicine, Jen-Ai Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/NRL.0b013e31815cffae","article-title":"Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States.","volume":"14","author":"Lakshminarayan","year":"2008","journal-title":"Neurologist"},{"key":"R2-20250503","first-page":"1069","article-title":"Understanding and managing atrial fibrillation in patients with kidney disease.","volume":"7","author":"Khouri","year":"2015","journal-title":"J Atr Fibrillation"},{"key":"R3-20250503","first-page":"e27753","article-title":"Atrial fibrillation in chronic kidney disease: an overview.","volume":"14","author":"Gadde","year":"2022","journal-title":"Cureus"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000516647","article-title":"Defining AKD: the spectrum of AKI, AKD, and CKD.","volume":"146","author":"Levey","year":"2022","journal-title":"Nephron"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"2054358119892372","DOI":"10.1177\/2054358119892372","article-title":"The risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease.","volume":"6","author":"Mace-Brickman","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"c4249","DOI":"10.1136\/bmj.c4249","article-title":"Low glomerular filtration rate and risk of stroke: meta-analysis.","volume":"341","author":"Lee","year":"2010","journal-title":"BMJ"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"e2343","DOI":"10.1097\/MD.0000000000002343","article-title":"Heart-carotid pulse wave velocity a useful index of atherosclerosis in Chinese hypertensive patients.","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"e3864","DOI":"10.1097\/MD.0000000000003864","article-title":"Influence of blood pressure variability on early carotid atherosclerosis in hypertension with and without diabetes.","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.113.000869","article-title":"Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.","volume":"6","author":"Kornej","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.amjmed.2017.04.015","article-title":"Renal function considerations for stroke prevention in atrial fibrillation.","volume":"130","author":"Fanikos","year":"2017","journal-title":"Am J Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease.","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.kint.2016.11.028","article-title":"Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?","volume":"91","author":"Heine","year":"2017","journal-title":"Kidney Int"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.13811217","article-title":"Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation.","volume":"13","author":"Shin","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCIMAGING.113.001317","article-title":"Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation.","volume":"7","author":"Yamamoto","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/CIRCEP.115.003188","article-title":"Left atrial appendage remodeling after lariat left atrial appendage ligation.","volume":"8","author":"Kreidieh","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R16-20250503","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.","volume":"38","author":"Piccini","year":"2017","journal-title":"Eur Heart J"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.19102\/icrm.2018.090402","article-title":"Left atrial appendage occlusion: what are the options and where is the evidence?","volume":"9","author":"Chava","year":"2018","journal-title":"J Innov Card Rhythm Manag"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage.","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"300060520966478","DOI":"10.1177\/0300060520966478","article-title":"Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion.","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/jce.14182","article-title":"Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation.","volume":"30","author":"Black-Maier","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"443","DOI":"10.31083\/j.rcm.2020.03.62","article-title":"Efficacy and safety of left atrial appendage occlusion in atrial fibrillation patients with chronic kidney disease: a systematic review and meta-analysis.","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/jcm10030440","article-title":"Impact of chronic kidney disease on chronic total occlusion revascularization outcomes: a meta-analysis.","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"e14173","DOI":"10.1111\/ijcp.14173","article-title":"Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: a meta-analysis.","volume":"75","author":"Lee","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.01.003","article-title":"Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.","volume":"207","author":"Kefer","year":"2016","journal-title":"Int J Cardiol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s00380-018-1157-x","article-title":"Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.","volume":"33","author":"Xue","year":"2018","journal-title":"Heart Vessels"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/00015385.2019.1585643","article-title":"Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.","volume":"75","author":"Brockmeyer","year":"2020","journal-title":"Acta Cardiol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00392-020-01638-5","article-title":"Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.","volume":"110","author":"Fastner","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"R28-20250503","first-page":"43","article-title":"Long-term results of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and chronic kidney disease.","volume":"18","author":"Michlicka-K\u0142y\u015b","year":"2022","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nefroe.2022.05.006","article-title":"Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: a single center experience.","volume":"42","author":"Benini Tapias","year":"2022","journal-title":"Nefrologia (Engl Ed)"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5114\/aoms.2020.92987","article-title":"Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.","volume":"19","author":"Lind","year":"2020","journal-title":"Arch Med Sci"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"e0287928","DOI":"10.1371\/journal.pone.0287928","article-title":"Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2023.01.007","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure.","volume":"20","author":"Saw","year":"2023","journal-title":"Heart Rhythm"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion.","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"e010195","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry.","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:32:51Z","timestamp":1746318771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":34,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038935","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}